Want to become a member
and enjoy the benefits?



Want to know about our
long term plans


We list career opportunities within the
Pharmaceutical and Toxicology
industries, and related fields

Looking for a job?



Australian Society of Clinical and Experimental Pharmacology and Toxicology

ASCEPT was founded in 1966, and held its first scientific meeting a year later. Since that time, ASCEPT has developed into the peak professional society devoted to advancing excellence in Clinical and Experimental Pharmacology and Toxicology in Australasia.

Latest News


Twitter Feed

Do you have a smaller event coming up that you’re unable to host face to face, such as a SIG meeting, planning day, team meeting, professional development workshop, or a speaker series? We can help #expertevents #hereforyou #international #virtualevents #onlineevents #contactus

"A memorable meeting, a celebration of science that transcends boundaries, and brings together the world pharmacology community." 💊🌍

Find out how you can help us achieve this for #WCP2022 in Professor Sir Munir Pirmohamed's latest blog: https://buff.ly/3k2iJcF

@MPUoL #WCP2022

Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin: https://buff.ly/33kW9pr

#covid19 #coronavirus #hydroxychloroquine #azithromycin

Calling all brilliant women in science, technology, engineering & mathematics - we’re looking for the next 60 #SuperstarsofSTEM! Applications are open now for women in STEM fields to join us for a targeted professional development program. Find out more: https://bit.ly/3gi1zW1

STEM sector: check out this brilliant new resource on Indigenous-led protocols on caring for Country: Our Knowledge, Our Way. It has been developed between Indigenous knowledge holders, ⁦@CSIRO⁩ & ⁦@NESPNorthern⁩. https://www.csiro.au/en/Research/LWF/Areas/Pathways/Sustainable-Indigenous/Our-Knowledge-Our-Way

Load More...

Upcoming Events

ASCEPT-PAGANZ 2019 Joint Scientific Meeting

Rydges Lakeland Resort, Queenstown, New Zealand
25 – 29 November 2019

Call for abstracts + registration opens
Monday 15 April
Abstract submission deadline
Monday 9 September
Early bird registration deadline + accommodation booking deadline
Monday 21 October


ASCEPT members have many diverse interests and so have formed Special Interest Groups to acknowledge these strengths, to enhance the cohesion of the Society and to promote and advance the study and application of pharmacology and toxicology in its broadest context. Currently, there are SIGs in the following areas.

Respiratory and Inflammation

The Respiratory & Inflammation SIG aims to facilitate cutting edge research in the areas of respiratory and inflammatory diseases.

Clinical Pharmacology

Clinical Pharmacology involves all aspects of safe, effective and rational use of medicines in humans (individual, group, or population levels).


The Cardiovascular SIG (formed in 2008) aims to foster collaboration and exchange of ideas across all areas of cardiovascular research.

Drug Disposition and Response

Drug Disposition and Response involves the distribution, metabolism and excretion of drug and the relationship between drug concentrations and effects.

Drug Discovery

Education Forum

A conduit for the sharing of ideas and resources between those involved in pharmacology education, with the overall aim of ensuring that all students of pharmacology receive a quality education that prepares them for their future careers.


The Pharmacogenomics SIG addresses molecular mechanisms, clinical impact and public health implications of genomics affecting drug response and adverse effects.

Student Forum

The Student Forum is currently under construction and will be available in the near future.

New Zealand Forum

To provide an annual forum to promote and disseminate pharmacology & toxicology research, clinical practice and education within New Zealand and beyond


Open to all who have an interest in toxicology. Including but not limited to drugs, medicines and consumer product toxicity, pesticides and agrichemicals, nanomaterials, occupational chemicals and industrial pollutants, naturally occurring toxic chemicals and poisons, poisoning management and clinical toxicity.

Urogenital and Gastrointestinal

The Urogenital/Gastrointestinal SIG promotes research in the field of urogenital and gastrointestinal
pharmacology and disseminate findings to Australian researchers while encouraging early career
researchers with opportunities to present their work.


The Neuropharmacology and behavioural SIG is interested in how drugs affect cellular activity within the nervous system and how this influences behaviour.


The role of the Pharmacoepidemiology SIG is to promote and support pharmacoepidemiological research and collaboration within ASCEPT members.



Professor Carl Kirkpatrick


Faculty of Pharmacy & Pharmaceutical Sciences, Monash University

Dr Danijela Gnjidic

President Elect

School of Pharmacy, Faculty of Medicine and Health, The University of Sydney

Professor Emilio Badoer


Medical Sciences, RMIT University

Dr Betty Exintaris

Board/Company Secretary

Faculty of Pharmacy & Pharmaceutical Sciences, Monash University